Oral Topotecan Versus Intravenous Docetaxel In Pretreated, Advanced Non-Small Cell Lung Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

760

Participants

Timeline

Start Date

October 31, 2001

Primary Completion Date

April 30, 2004

Conditions
Non-Small-Cell Lung Cancer
Interventions
DRUG

topotecan

Trial Locations (114)

100

GSK Investigational Site, Taipei

333

GSK Investigational Site, Tau-Yuan County

1100

GSK Investigational Site, Quezon City

1200

GSK Investigational Site, Brussels

1529

GSK Investigational Site, Budapest

2650

GSK Investigational Site, Edegem

2930

GSK Investigational Site, Braasschaat

3004

GSK Investigational Site, Melbourne

3128

GSK Investigational Site, Ringwood East

3510

GSK Investigational Site, Izmir

3529

GSK Investigational Site, Miskolc

4000

GSK Investigational Site, Liège

5000

GSK Investigational Site, Adelaide

5042

GSK Investigational Site, Bedford Park

6001

GSK Investigational Site, Port Elizabeth

6002

GSK Investigational Site, Newtown, Wellington

9300

GSK Investigational Site, Csorna

10126

GSK Investigational Site, Turin

10400

GSK Investigational Site, Bangkok

11526

GSK Investigational Site, Athens

14059

GSK Investigational Site, Prague

14076

GSK Investigational Site, Caen

14109

GSK Investigational Site, Berlin

14929

GSK Investigational Site, Treuenbrietzen

15669

GSK Investigational Site, Papagos, Athens

20520

GSK Investigational Site, Turku

21075

GSK Investigational Site, Hamburg

21079

GSK Investigational Site, Dijon

23007

GSK Investigational Site, Jaén

25198

GSK Investigational Site, Lleida

28007

GSK Investigational Site, Madrid

28040

GSK Investigational Site, Madrid

28047

GSK Investigational Site, Madrid

29020

GSK Investigational Site, Málaga

34280

GSK Investigational Site, Istanbul

36002

GSK Investigational Site, Pontevedra

37135

GSK Investigational Site, Verona

38320

GSK Investigational Site, La Laguna (Santa Cruz de Tenerife)

46009

GSK Investigational Site, Valencia

48903

GSK Investigational Site, Barakaldo (Vizcaya)

50200

GSK Investigational Site, Chiang Mai

52621

GSK Investigational Site, Ramat Gan

54007

GSK Investigational Site, Thessaloniki

64239

GSK Investigational Site, Tel Aviv

67098

GSK Investigational Site, Strasbourg

70014

GSK Investigational Site, Vesoul

71110

GSK Investigational Site, Heraklion, Crete

78306

GSK Investigational Site, Ashkelon

79031

GSK Investigational Site, Lviv

80336

GSK Investigational Site, Munich

82131

GSK Investigational Site, Gauting

83800

GSK Investigational Site, Toulon Naval

84101

GSK Investigational Site, Beersheba

93049

GSK Investigational Site, Regensburg

99437

GSK Investigational Site, Bad Berka

100036

GSK Investigational Site, Beijing

100730

GSK Investigational Site, Wangfujing, Beijing

119074

GSK Investigational Site, Singapore

198255

GSK Investigational Site, Saint Petersburg

200433

GSK Investigational Site, Shanghai

443066

GSK Investigational Site, Samara

710061

GSK Investigational Site, Xi'an

A-6020

GSK Investigational Site, Innsbruck

A-3100

GSK Investigational Site, Sankt Pölten

A-1220

GSK Investigational Site, Vienna

B1P 1P3

GSK Investigational Site, Sydney

L1G 2B9

GSK Investigational Site, Oshawa

P7B 6V4

GSK Investigational Site, Thunder Bay

M5G 2M9

GSK Investigational Site, Toronto

M6S 1B5

GSK Investigational Site, Toronto

J4V 2H1

GSK Investigational Site, Greenfield Park

H3A 1A1

GSK Investigational Site, Montreal

G1V 4G5

GSK Investigational Site, Sainte-Foy

Unknown

GSK Investigational Site, Shanghai

GSK Investigational Site, Tianjin

GSK Investigational Site, Herlev

GSK Investigational Site, Pretoria

GSK Investigational Site, Cape Town

GSK Investigational Site, Kharkiv

GSK Investigational Site, Luhansk

GSK Investigational Site, Nottingham

370 87

GSK Investigational Site, České Budějovice

140 59

GSK Investigational Site, Kladno

DK-5000

GSK Investigational Site, Odense C

00029

GSK Investigational Site, Helsinki

04207

GSK Investigational Site, Leipzig

265 00

GSK Investigational Site, Rio, Patras

00149

GSK Investigational Site, Rome

07100

GSK Investigational Site, Sassari

06122

GSK Investigational Site, Perugia

LV 1002

GSK Investigational Site, Riga

LV 1079

GSK Investigational Site, Riga

LT-50009

GSK Investigational Site, Kaunas

LT-08660

GSK Investigational Site, Vilnius

5211 NL

GSK Investigational Site, 's-Hertogenbosch

2625 AD

GSK Investigational Site, Delft

9721 SW

GSK Investigational Site, Groningen

6419 PC

GSK Investigational Site, Heerlen

8934 AD

GSK Investigational Site, Leeuwarden

60-569

GSK Investigational Site, Poznan

02-781

GSK Investigational Site, Warsaw

1769-166

GSK Investigational Site, Lisbon

4200-319

GSK Investigational Site, Porto

115 478

GSK Investigational Site, Moscow

117 837

GSK Investigational Site, Moscow

129 128

GSK Investigational Site, Moscow

603 000

GSK Investigational Site, Nizhny Novgorod

07014

GSK Investigational Site, Palma de Mallorca

CH-8091

GSK Investigational Site, Zurich

DD1 9SY

GSK Investigational Site, Dundee

G4 0SF

GSK Investigational Site, Glasgow

LE1 5WW

GSK Investigational Site, Leicester

SE1 9RT

GSK Investigational Site, London

GU2 7XX

GSK Investigational Site, Guildford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY